Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: Austria Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20064
20071
20082
20092
20104
20113
20123
20134
20143
20152
20161
20191
20212
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated4
Active, not recruiting2
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim13
AstraZeneca10
Novartis Pharmaceuticals6
GlaxoSmithKline4
Chiesi Farmaceutici S.p.A.2
Hoffmann-La Roche2
Pearl Therapeutics, Inc.2
Broncus Technologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive40
Bronchitis, Chronic2
Emphysema2
Lung Diseases2
Bronchial Diseases1
Bronchiolitis Obliterans Syndrome1
Bronchitis1
Cardiovascular Diseases1
Lung Diseases, Obstructive1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.